Headquarters
La Jolla, CA
Industry
Life Sciences – Biotechnology
Overview
Advanced Biohealing is a leader in commercializing living cell therapies, a cornerstone technology in the field of regenerative medicine that repairs damaged human tissue and enables the body to heal itself. The Company currently manufactures and markets Dermagraft®, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process. Dermagraft is approved by the FDA for the treatment of diabetic foot ulcers.
Solution
QAD ERP was implemented as a robust enterprise platform for expansion and growth.
Results
Advanced Biohealing was acquired by Shire Plc for approximately $750 million in 2011.
